Browsing by Author "Alshikho, Mohamad"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndrome
    (Springer Nature, 2024-05-29) Lao, Patrick; Edwards, Natalie; Flores‑Aguilar, Lisi; Alshikho, Mohamad; Rizvi, Batool; Tudorascu, Dana; Rosas, H. Diana; Yassa, Michael; Christian, Bradley T.; Mapstone, Mark; Handen, Benjamin; Zimmerman, Molly E.; Gutierrez, Jose; Wilcock, Donna; Head, Elizabeth; Brickman, Adam M.; Neurology, School of Medicine
    Adults with Down syndrome have a genetic form of Alzheimer's disease (AD) and evidence of cerebrovascular disease across the AD continuum, despite few systemic vascular risk factors. The onset and progression of AD in Down syndrome is highly age-dependent, but it is unknown at what age cerebrovascular disease emerges and what factors influence its severity. In the Alzheimer's Biomarker Consortium-Down Syndrome study (ABC-DS; n = 242; age = 25-72), we estimated the age inflection point at which MRI-based white matter hyperintensities (WMH), enlarged perivascular spaces (PVS), microbleeds, and infarcts emerge in relation to demographic data, risk factors, amyloid and tau, and AD diagnosis. Enlarged PVS and infarcts appear to develop in the early 30s, while microbleeds, WMH, amyloid, and tau emerge in the mid to late 30s. Age-residualized WMH were higher in women, in individuals with dementia, and with lower body mass index. Participants with hypertension and APOE-ε4 had higher age-residualized PVS and microbleeds, respectively. Lifespan trajectories demonstrate a dramatic cerebrovascular profile in adults with Down syndrome that appears to evolve developmentally in parallel with AD pathophysiology approximately two decades prior to dementia symptoms.